Literature DB >> 8042047

Combined modality therapy in the treatment of esophageal cancer.

D H Ilson1, D P Kelsen.   

Abstract

Entities:  

Mesh:

Year:  1994        PMID: 8042047

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  7 in total

1.  Extended lymphadenectomy in esophageal cancer is crucial.

Authors:  Daniel Tong; Simon Law
Journal:  World J Surg       Date:  2013-08       Impact factor: 3.352

2.  Does neoadjuvant chemotherapy for carcinoma in the thoracic esophagus increase postoperative morbidity?

Authors:  Y Tabira; T Okuma; K Kondo; M Yoshioka; T Mori; M Tanaka; K Nakano; N Kitamura
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1999-08

3.  Implications of Bit1 and AIF overexpressions in esophageal squamous cell carcinoma.

Authors:  Tianli Fan; Fang Tian; Shanyong Yi; Yang Ke; Shengna Han; Lirong Zhang; Hongtao Liu
Journal:  Tumour Biol       Date:  2013-08-17

4.  First-line chemotherapy improves the resection rate and long-term survival of locally advanced (T4, any N, M0) squamous cell carcinoma of the thoracic esophagus: final report on 163 consecutive patients with 5-year follow-up.

Authors:  E Ancona; A Ruol; C Castoro; V Chiarion-Sileni; S Merigliano; S Santi; L Bonavina; A Peracchia
Journal:  Ann Surg       Date:  1997-12       Impact factor: 12.969

5.  Downstaging of esophageal cancer after preoperative radiation and chemotherapy.

Authors:  S B Vogel; W M Mendenhall; M D Sombeck; R Marsh; E R Woodward
Journal:  Ann Surg       Date:  1995-06       Impact factor: 12.969

6.  Down-regulation of platelet-derived growth factor-D expression blockades NF-κB pathway to inhibit cell proliferation and invasion as well as induce apoptosis in esophageal squamous cell carcinoma.

Authors:  Yu Han; Xiao-He Guo; Qing-Fen Zheng; Yan-Li Zhu; Ying-Ying Fan; Xiu-Ying Zhang
Journal:  Mol Biol Rep       Date:  2012-11-28       Impact factor: 2.316

7.  Detection of occult lymph node metastases in esophageal cancer by minimally invasive staging combined with molecular diagnostic techniques.

Authors:  E S Kassis; N Nguyen; S P Shriver; J M Siegfried; P R Schauer; J D Luketich
Journal:  JSLS       Date:  1998 Oct-Dec       Impact factor: 2.172

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.